You are here

drug pricing

Biopharma ramps up lobbying spend as drug pricing legislation nears

Biopharma ramps up lobbying spend as drug pricing legislation nears

Endpoints

Teva Pharmaceutical

Flag link:

New Kaiser analysis shows how limiting price negotiations to targeted drugs may better focus upcoming legislation

New Kaiser analysis shows how limiting price negotiations to targeted drugs may better focus upcoming legislation

Endpoints

Flag link:

3 changes coming to drug pricing

3 changes coming to drug pricing

MedCity News

Flag link:

CBO Report Shows Enacting Drug Pricing Legislation Will Result In Fewer New Drugs

CBO Report Shows Enacting Drug Pricing Legislation Will Result In Fewer New Drugs

Forbes

Flag link:

Life sciences pumping more cash than ever into R&D, but drug pricing limits could stymie that tide: report

Life sciences pumping more cash than ever into R&D, but drug pricing limits could stymie that tide: report

Fierce Pharma

Flag link:

Bills, Bills, Bills: Congress Advances Bills to Address Drug Competition

Bills, Bills, Bills: Congress Advances Bills to Address Drug Competition

FDA Law Blog

Flag link:

How Biden’s infrastructure plan will go after biopharma companies beyond drug pricing

How Biden’s infrastructure plan will go after biopharma companies beyond drug pricing

Endpoints

Flag link:

Lawmakers are once again eyeing drug prices—and this time, the threat to pharma is real: analysts

Lawmakers are once again eyeing drug prices—and this time, the threat to pharma is real: analysts

Fierce Pharma

Flag link:

‘A mess across the board’: Senate committee kicks off talks on drug pricing reforms

‘A mess across the board’: Senate committee kicks off talks on drug pricing reforms

Endpoints

Flag link:

Rising costs force 39% of Americans to skip, ration meds, survey says

Rising costs force 39% of Americans to skip, ration meds, survey says

Beckers Hospital Review

Flag link:

The top drugs that could be impacted by an obscure provision in the pandemic relief law

The top drugs that could be impacted by an obscure provision in the pandemic relief law

BioPharma Dive

Flag link:

Countering payers, drugmakers say net prices declined in 2020

Countering payers, drugmakers say net prices declined in 2020

BioPharma Dive

Flag link:

Several states are proposing laws to cut drug prices

Several states are proposing laws to cut drug prices

Beckers Hospital Review

Flag link:

As COVID-19 becomes a business, vaccine makers confront thorny pricing questions

As COVID-19 becomes a business, vaccine makers confront thorny pricing questions

BioPharma Dive

Flag link:

Could a Senate drug pricing bill be 'a positive' for pharma? One analyst says so

Could a Senate drug pricing bill be 'a positive' for pharma? One analyst says so

Fierce Pharma

Flag link:

Most Favored Nation Drug Pricing Rule on Hold Awaiting Changes

Most Favored Nation Drug Pricing Rule on Hold Awaiting Changes

FDA Law Blog

Medicare Part B

most favored nation

Flag link:

Drug price hikes without new evidence upped spending by $1.2B, ICER says

Drug price hikes without new evidence upped spending by $1.2B, ICER says

MedCity News

Flag link:

Perspective: Drug price transparency in the Biden era

Perspective: Drug price transparency in the Biden era

RAPS.org

Flag link:

Insulin’s Out-Of-Pocket Cost Burden To Diabetic Patients Continues To Rise Despite Reduced Net Costs To PBMs

Insulin’s Out-Of-Pocket Cost Burden To Diabetic Patients Continues To Rise Despite Reduced Net Costs To PBMs

Forbes

Flag link:

Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes

Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes

Fierce Pharma

Teva Pharmaceutical

Gilead Sciences

Flag link:

Pages